HOUSE AMENDMENT
Bill No. HB 1E CS
   
1 CHAMBER ACTION
2
Senate House
3 .
4 .
5 .
6         
7         
8         
9         
10         
11         
12          Representative Ryan offered the following:
13         
14          Amendment
15          Remove lines 429-469, and insert:
16         
17          (a) The grantee shall reinvest a percentage of the net
18    royalty revenues and of the revenues from the sale of stock
19    received by The Scripps Research Institute from the licensing or
20    transfer of inventions, methods, processes, and other patentable
21    activities conceived or reduced to practice using facilities or
22    employees of the grantee following the execution of the contract
23    between the corporation and the grantee, as provided in
24    paragraph (c). For purposes of this paragraph, the term “net
25    royalty revenues” means all royalty revenues less the cost of
26    obtaining, maintaining, and enforcing related patent and
27    intellectual property rights, both foreign and domestic.
28    Reinvestment payments under this subsection shall commence no
29    later than 6 months after the grantee has received the final
30    disbursement under the contract and continue until the grantee
31    has reinvested pursuant to paragraph (c) the percentage of all
32    the net royalty revenues and proceeds from the sale of stock
33    related to the grantee’s operation after the execution of the
34    contract.
35          (b) The grantee shall reinvest a percentage of the gross
36    revenues it receives from naming opportunities associated with
37    any facility it builds in this state, as provided in paragraph
38    (c). For purposes of this paragraph, the term “naming
39    opportunities” includes charitable donations from any person in
40    consideration for the right to have all or a portion of the
41    facility named for or in the memory of any person, living or
42    dead, or for any entity. The obligation to make reinvestment
43    payments under this subsection shall commence upon the execution
44    of the contract between the corporation and the grantee.
45          (c) The total amount of revenues reinvested by the grantee
46    under this subsection shall be:
47          1. Fifteen percent of up to $155 million in such revenues,
48    or $200 million if performance measures are not met.
49          2. Ten percent thereafter up to $300 million in such
50    revenues, or $369 million if performance measures are not met.
51          3. Five percent thereafter.
52         
53          All reinvestment payments made pursuant to this subsection shall
54    be remitted to the state for deposit in the Biomedical Research
55    Trust Fund, or if such fund has ceased to exist, in another
56    trust fund that supports biomedical research, as determined by
57    law.
58